February 28, 2022 – Research from the University of Cincinnati is examining a protein that plays a key role in heart failure.  

February 28, 2022 – Despite improvements in treatment and increased public awareness about prevention, cardiovascular disease (CVD) is still the leading cause of death worldwide. CVD causes half of all deaths in several developed countries and is the major cause of adult death in many developing countries. And though some cardiovascular events aren't fatal, strokes and other forms of heart disease may still be debilitating enough to seriously affect functional ability.

February 25, 2022 – Teleflex Incorporated, a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI).

Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool that can effectively identify and distinguish between two life-threatening heart conditions that are often easy to miss: hypertrophic cardiomyopathy and cardiac amyloidosis. The new findings were published in JAMA Cardiology. 

February 25, 2022 – Researchers at the University of Louisville analyzed data for heart transplants from 1987 to 2019 to better understand equity in access to heart transplant for adult Black and white patients and those of other races, comparing percentages of patients who were placed on the transplant list and those actually transplanted over time. They found that access to transplants for Black patients has improved significantly over the study period, both in the percentage of patients listed for transplant and the percentage of transplants performed.